ARTICLE | Top Story
British Biotech metalloenzyme deal
October 17, 2000 7:00 AM UTC
British Biotech (LSE:BBG; BBIOY) and Serono (SWX:SEO; SRA) will exclusively research, develop and commercialize BBG's metalloenzyme inhibitors to treat inflammatory diseases. The partners will identif...